Geography of clinical cancer research publications from 1995 to 1999
Geography of clinical cancer research publications from 1995 to 1999
复制标题
DOI：
10.1016/s0959-8049(02)00239-3
复制
发表时间：
2003-01-01
影响因子：
8.4
通讯作者：
Rosso, R
中科院分区：
文献类型：
--
作者：
Grossi, F;Belvedere, O;Rosso, R
在本文中，我们研究了 1995 年至 1999 年临床癌症研究出版物的地理分布。进行了 Medline 检索，以检索 1995 年至 1999 年发表的临床肿瘤学报告 I、II 和 III 期研究的论文。仅考虑报告抗母细胞化疗的研究，无论是单独的还是与其他治疗联合的。对于每个国家，确定了论文总数、总影响因子 (IF) 和平均 IF。进行了类似的计算来比较欧盟与北美。已识别出 3142 篇论文。美国的论文数量排名第一（37.7%），其次是意大利（9.8%）、英国（8.5%）和日本（6.9%）。与北美同事相比，欧洲机构的研究人员发表的论文数量更多（1362 篇对 1288 篇）。尽管如此，北美论文的平均 IF 仍高于欧洲地址的论文（3.54 与 3.14）。大多数 I 期研究在北美进行，而大多数 III 期研究在欧洲进行。这些结果提供了全球临床癌症研究的地理信息，这可能反映了该领域涉及的人力和经济资源。 (C) 2002 Elsevier Science Ltd. 保留所有权利。
In this paper, we study the geography of publications in clinical cancer research from 1995 to 1999. A Medline search was performed to retrieve papers in clinical oncology reporting phase I, II and III studies published between 1995 and 1999. Only studies reporting antiblastic chemotherapy have been considered, either alone or in combination with other treatments. For each country, the total number of papers, the total Impact Factor (IF), and the mean IF were determined. Similar calculations were performed to compare the European Union versus North America. 3142 papers were identified. The United States ranks first by number of papers (37.7% share), followed by Italy (9.8%), the United Kingdom (8.5%) and Japan (6.9%). Investigators at European institutions published a higher number of papers compared with their North American colleagues (1362 versus 1288). Still the mean IF of North American papers is higher than the papers with a European address (3.54 versus 3.14). The majority of phase I studies were performed in North America, while most of phase III studies were performed in Europe. These results provide information on the geography of clinical cancer research worldwide, which may reflect the human and economic resources involved in this field. (C) 2002 Elsevier Science Ltd. All rights reserved.